- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this latest study, the 2020 growth of Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Influenza Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
For Children (6 months to 3 years)
For Adults and Children over 3 years
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Vaccine Consumption 2016-2026
2.1.2 Influenza Vaccine Consumption CAGR by Region
2.2 Influenza Vaccine Segment by Type
2.2.1 Whole Virus Vaccines
2.2.2 Split Virus Vaccines
2.2.3 Subunit Vaccines
2.2.4 Live Attenuated Virus Vaccines
2.3 Influenza Vaccine Sales by Type
2.3.1 Global Influenza Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Influenza Vaccine Sale Price by Type (2016-2021)
2.4 Influenza Vaccine Segment by Application
2.4.1 For Children (6 months to 3 years)
2.4.2 For Adults and Children over 3 years
2.5 Influenza Vaccine Sales by Application
2.5.1 Global Influenza Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Influenza Vaccine Sale Price by Application (2016-2021)
3 Global Influenza Vaccine by Company
3.1 Global Influenza Vaccine Sales Market Share by Company
3.1.1 Global Influenza Vaccine Sales by Company (2019-2021)
3.1.2 Global Influenza Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Influenza Vaccine Revenue Market Share by Company
3.2.1 Global Influenza Vaccine Revenue by Company (2019-2021)
3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Influenza Vaccine Sale Price by Company
3.4 Global Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution
3.4.2 Players Influenza Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Influenza Vaccine by Region
4.1 Global Influenza Vaccine by Region
4.1.1 Global Influenza Vaccine Sales by Region
4.1.2 Global Influenza Vaccine Revenue by Region
4.2 Americas Influenza Vaccine Sales Growth
4.3 APAC Influenza Vaccine Sales Growth
4.4 Europe Influenza Vaccine Sales Growth
4.5 Middle East & Africa Influenza Vaccine Sales Growth
5 Americas
5.1 Americas Influenza Vaccine Sales by Country
5.1.1 Americas Influenza Vaccine Sales by Country (2016-2021)
5.1.2 Americas Influenza Vaccine Revenue by Country (2016-2021)
5.2 Americas Influenza Vaccine Sales by Type
5.3 Americas Influenza Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza Vaccine Sales by Region
6.1.1 APAC Influenza Vaccine Sales by Region (2016-2021)
6.1.2 APAC Influenza Vaccine Revenue by Region (2016-2021)
6.2 APAC Influenza Vaccine Sales by Type
6.3 APAC Influenza Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Influenza Vaccine by Country
7.1.1 Europe Influenza Vaccine Sales by Country (2016-2021)
7.1.2 Europe Influenza Vaccine Revenue by Country (2016-2021)
7.2 Europe Influenza Vaccine Sales by Type
7.3 Europe Influenza Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Influenza Vaccine by Country
8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Influenza Vaccine Sales by Type
8.3 Middle East & Africa Influenza Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Vaccine Distributors
10.3 Influenza Vaccine Customer
11 Global Influenza Vaccine Market Forecast
11.1 Global Influenza Vaccine Forecast by Region
11.1.1 Global Influenza Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Influenza Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Influenza Vaccine Forecast by Type
11.7 Global Influenza Vaccine Forecast by Application
12 Key Players Analysis
12.1 CSL
12.1.1 CSL CSL Company Information
12.1.2 CSL Influenza Vaccine Product Offered
12.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 CSL Main Business Overview
12.1.5 CSL Latest Developments
12.2 GSK
12.2.1 GSK Company Information
12.2.2 GSK Influenza Vaccine Product Offered
12.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 GSK Main Business Overview
12.2.5 GSK Latest Developments
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Company Information
12.3.2 Sanofi Pasteur Influenza Vaccine Product Offered
12.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi Pasteur Main Business Overview
12.3.5 Sanofi Pasteur Latest Developments
12.4 Mylan
12.4.1 Mylan Company Information
12.4.2 Mylan Influenza Vaccine Product Offered
12.4.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mylan Main Business Overview
12.4.5 Mylan Latest Developments
12.5 AstraZeneca
12.5.1 AstraZeneca Company Information
12.5.2 AstraZeneca Influenza Vaccine Product Offered
12.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 AstraZeneca Main Business Overview
12.5.5 AstraZeneca Latest Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Influenza Vaccine Product Offered
12.6.3 Pfizer Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pfizer Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Information
12.7.2 Johnson & Johnson Influenza Vaccine Product Offered
12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Johnson & Johnson Main Business Overview
12.7.5 Johnson & Johnson Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Influenza Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Whole Virus Vaccines
Table 3. Major Players of Split Virus Vaccines
Table 4. Major Players of Subunit Vaccines
Table 5. Major Players of Live Attenuated Virus Vaccines
Table 6. Global Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 7. Global Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 8. Global Influenza Vaccine Revenue by Type (2016-2021) & ($ million)
Table 9. Global Influenza Vaccine Revenue Market Share by Type (2016-2021)
Table 10. Global Influenza Vaccine Sale Price by Type (2016-2021)
Table 11. Global Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 12. Global Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 13. Global Influenza Vaccine Value by Application (2016-2021)
Table 14. Global Influenza Vaccine Revenue Market Share by Application (2016-2021)
Table 15. Global Influenza Vaccine Sale Price by Application (2016-2021)
Table 16. Global Influenza Vaccine Sales by Company (2019-2021) & (K Doses)
Table 17. Global Influenza Vaccine Sales Market Share by Company (2019-2021)
Table 18. Global Influenza Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Influenza Vaccine Revenue Market Share by Company (2019-2021)
Table 20. Global Influenza Vaccine Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area
Table 22. Players Influenza Vaccine Products Offered
Table 23. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Influenza Vaccine Sales by Region (2016-2021) (K Doses)
Table 27. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 28. Global Influenza Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 30. Americas Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 31. Americas Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 32. Americas Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 34. Americas Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 35. Americas Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 36. Americas Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 37. Americas Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 38. APAC Influenza Vaccine Sales by Region (2016-2021) & (K Doses)
Table 39. APAC Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 40. APAC Influenza Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Influenza Vaccine Revenue Market Share by Region (2016-2021)
Table 42. APAC Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 43. APAC Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 44. APAC Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 45. APAC Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 46. Europe Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 47. Europe Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 48. Europe Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 50. Europe Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 51. Europe Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 52. Europe Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 53. Europe Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Influenza Vaccine Sales by Country (2016-2021) & (K Doses)
Table 55. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 59. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 61. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 62. Global Influenza Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
Table 63. Global Influenza Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 64. Global Influenza Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 65. Global Influenza Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 66. Global Influenza Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
Table 67. Global Influenza Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 68. Global Influenza Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 69. Global Influenza Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 70. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 71. CSL Influenza Vaccine Product Offered
Table 72. CSL Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 73. CSL Main Business
Table 74. CSL Latest Developments
Table 75. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 76. GSK Influenza Vaccine Product Offered
Table 77. GSK Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 78. GSK Main Business
Table 79. GSK Latest Developments
Table 80. Sanofi Pasteur Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Sanofi Pasteur Influenza Vaccine Product Offered
Table 82. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 83. Sanofi Pasteur Main Business
Table 84. Sanofi Pasteur Latest Developments
Table 85. Mylan Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Mylan Influenza Vaccine Product Offered
Table 87. Mylan Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 88. Mylan Main Business
Table 89. Mylan Latest Developments
Table 90. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. AstraZeneca Influenza Vaccine Product Offered
Table 92. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 93. AstraZeneca Main Business
Table 94. AstraZeneca Latest Developments
Table 95. Pfizer Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Influenza Vaccine Product Offered
Table 97. Pfizer Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Johnson & Johnson Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Johnson & Johnson Influenza Vaccine Product Offered
Table 102. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 103. Johnson & Johnson Main Business
Table 104. Johnson & Johnson Latest Developments
List of Figures
Figure 1. Picture of Influenza Vaccine
Figure 2. Influenza Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Influenza Vaccine Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Influenza Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Influenza Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Whole Virus Vaccines
Figure 10. Product Picture of Split Virus Vaccines
Figure 11. Product Picture of Subunit Vaccines
Figure 12. Product Picture of Live Attenuated Virus Vaccines
Figure 13. Global Influenza Vaccine Sales Market Share by Type in 2020
Figure 14. Global Influenza Vaccine Revenue Market Share by Type (2016-2021)
Figure 15. Influenza Vaccine Consumed in For Children (6 months to 3 years)
Figure 16. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2016-2021) & (K Doses)
Figure 17. Influenza Vaccine Consumed in For Adults and Children over 3 years
Figure 18. Global Influenza Vaccine Market: For Adults and Children over 3 years (2016-2021) & (K Doses)
Figure 19. Global Influenza Vaccine Sales Market Share by Application (2016-2021)
Figure 20. Global Influenza Vaccine Revenue Market Share by Application in 2020
Figure 21. Global Influenza Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Influenza Vaccine Revenue Market Share by Company in 2020
Figure 23. Global Influenza Vaccine Sales Market Share by Regions (2016-2021)
Figure 24. Global Influenza Vaccine Revenue Market Share by Region in 2020
Figure 25. Americas Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 26. Americas Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 27. APAC Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 28. APAC Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 29. Europe Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 30. Europe Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Influenza Vaccine Sales 2016-2021 (K Doses)
Figure 32. Middle East & Africa Influenza Vaccine Revenue 2016-2021 ($ Millions)
Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2020
Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2020
Figure 35. Americas Influenza Vaccine Sales Market Share by Type in 2020
Figure 36. Americas Influenza Vaccine Sales Market Share by Application in 2020
Figure 37. United States Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Influenza Vaccine Sales Market Share by Region in 2020
Figure 42. APAC Influenza Vaccine Revenue Market Share by Regions in 2020
Figure 43. APAC Influenza Vaccine Sales Market Share by Type in 2020
Figure 44. APAC Influenza Vaccine Sales Market Share by Application in 2020
Figure 45. China Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Influenza Vaccine Sales Market Share by Country in 2020
Figure 52. Europe Influenza Vaccine Revenue Market Share by Country in 2020
Figure 53. Europe Influenza Vaccine Sales Market Share by Type in 2020
Figure 54. Europe Influenza Vaccine Sales Market Share by Application in 2020
Figure 55. Germany Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Influenza Vaccine Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Influenza Vaccine Sales Market Share by Application in 2020
Figure 64. Egypt Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
